Clinical Trial Update: Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection

View source ↗

Summary

A completed clinical study evaluating circulating tumor DNA (ctDNA) in patients with Non-Small Cell Lung Cancer following surgical resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED